Claude 4.7 claims to discover and design new enzymes, helping the synthetic biology field regain capital favor with AI

Claude 4.7 claims to discover and design new enzymes, helping the synthetic biology field regain capital favor with AI. AI reduces the enzyme development cycle by about 80% and is used to optimize metabolic pathways involving multiple enzyme collaborations within cells. AI cannot yet replace human decision-making but is already used to predict risks and identify bottlenecks.